sulfasalazine has been researched along with Impaired Glucose Tolerance in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Maximum glucose intolerance was observed in patients who were on Non-HCQ drug combinations." | 1.46 | Prevalence of glucose intolerance in rheumatoid arthritis patients at a tertiary care centre in Haryana. ( Dangi, A; Rajput, R; Singh, H, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rajput, R | 1 |
| Dangi, A | 1 |
| Singh, H | 1 |
1 other study available for sulfasalazine and Impaired Glucose Tolerance
| Article | Year |
|---|---|
Prevalence of glucose intolerance in rheumatoid arthritis patients at a tertiary care centre in Haryana.
Topics: Adult; Arthritis, Rheumatoid; Body Mass Index; Drug Therapy, Combination; Female; Glucose Intoleranc | 2017 |